Journal of Circadian Rhythms (May 2012)

Chronotolerance study of the antiepileptic drug valproic acid in mice

  • Ben-Cherif Wafa,
  • Dridi Ichrak,
  • Aouam Karim,
  • Ben-Attia Mossadok,
  • Reinberg Alain,
  • Boughattas Naceur A

DOI
https://doi.org/10.1186/1740-3391-10-3
Journal volume & issue
Vol. 10, no. 1
p. 3

Abstract

Read online

Abstract Background Valproic acid (VPA) is an antiepileptic drug widely used for the treatment of absence seizures and generalized tonic-clonic seizures. The present work aims to study whether VPA-induced toxicity varies according to the dosing-time in the 24 hour-scale. Methods The influence of dosing-time on tolerance to VPA was investigated in 120 male Swiss mice synchronized under a light-dark cycle (12:12). The mean VPA lethal dose was first determined to be 850 ± 0.2 mg/kg, i.p.. Such a dose was administered by i.p. route to a total of 90 mice divided in six circadian stages [1, 5, 9, 13, 17 and 21 Hours After Light Onset (HALO)] (15 mice/circadian time); 30 mice were used as control (5 mice / circadian time). Results The surviving treated mice exhibited a significant circadian variation in rectal temperature and body weight loss (p 2 = 42.1, p Conclusions With regards to these data the optimal tolerance to VPA occurred when the drug was administered in the second half of the light-rest span of mice which is physiologically analogous to the second half of the night for human patients.

Keywords